Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Blood serum miRNA: Non-invasive biomarkers for Alzheimer's disease.
Geekiyanage H, Jicha GA, Nelson PT, Chan C.
Exp Neurol. 2012 Jun;235(2):491-6. Epub 2011 Dec 1.
Related citations
MicroRNA networks surrounding APP and amyloid-β metabolism - Implications for Alzheimer's disease.
Schonrock N, Matamales M, Ittner LM, Götz J.
Exp Neurol. 2012 Jun;235(2):447-54. Epub 2011 Nov 16.
Cellular model of Alzheimer's disease--relevance to therapeutic testing.
Marwarha G, Ghribi O.
Exp Neurol. 2012 Feb;233(2):733-9. Epub 2011 Nov 16. No abstract available.
Molecular network of microRNA targets in Alzheimer's disease brains.
Satoh J.
Exp Neurol. 2012 Jun;235(2):436-46. Epub 2011 Sep 16.
Recent advances in the development of immunotherapies for tauopathies.
Ubhi K, Masliah E.
Exp Neurol. 2011 Aug;230(2):157-61. Epub 2010 Oct 21.
Increased expression of three-repeat isoforms of tau contributes to tau pathology in a rat model of chronic type 2 diabetes.
Jung HJ, Park SS, Mok JO, Lee TK, Park CS, Park SA.
Exp Neurol. 2011 Apr;228(2):232-41. Epub 2011 Jan 31.
In vitro modelling of Alzheimer's disease: degeneration and cell death induced by viral delivery of amyloid and tau.
Stoppelkamp S, Bell HS, Palacios-Filardo J, Shewan DA, Riedel G, Platt B.
Exp Neurol. 2011 Jun;229(2):226-37. Epub 2011 Feb 2.
Effects of sex hormones on Alzheimer's disease-associated β-amyloid oligomer formation in vitro.
Morinaga A, Ono K, Takasaki J, Ikeda T, Hirohata M, Yamada M.
Exp Neurol. 2011 Apr;228(2):298-302. Epub 2011 Jan 31.
Atorvastatin and Aβ(1-40): not as simple as cholesterol reduction in brain and relevance to Alzheimer disease.
Butterfield DA.
Exp Neurol. 2011 Mar;228(1):15-8. Epub 2010 Dec 28. Review. No abstract available.
The plasma membrane redox system in Alzheimer's disease.
Adlard PA, Bush AI.
Exp Neurol. 2011 Mar;228(1):9-14. Epub 2010 Dec 17. Review. No abstract available.
The plasma membrane redox system is impaired by amyloid β-peptide and in the hippocampus and cerebral cortex of 3xTgAD mice.
Hyun DH, Mughal MR, Yang H, Lee JH, Ko EJ, Hunt ND, de Cabo R, Mattson MP.
Exp Neurol. 2010 Oct;225(2):423-9. Epub 2010 Jul 27.
The role of low-density receptor-related protein 1 (LRP1) as a competitive substrate of the amyloid precursor protein (APP) for BACE1.
von Einem B, Schwanzar D, Rehn F, Beyer AS, Weber P, Wagner M, Schneckenburger H, von Arnim CA.
Exp Neurol. 2010 Sep;225(1):85-93. Epub 2010 May 26.
Beyond the signaling effect role of amyloid-ß42 on the processing of APP, and its clinical implications.
Lahiri DK, Maloney B.
Exp Neurol. 2010 Sep;225(1):51-4. Epub 2010 May 5. Review.
Soluble oligomeric forms of beta-amyloid (Abeta) peptide stimulate Abeta production via astrogliosis in the rat brain.
Perez JL, Carrero I, Gonzalo P, Arevalo-Serrano J, Sanz-Anquela JM, Ortega J, Rodriguez M, Gonzalo-Ruiz A.
Exp Neurol. 2010 Jun;223(2):410-21. Epub 2009 Oct 29.
GSK3: a possible link between beta amyloid peptide and tau protein.
Hernández F, Gómez de Barreda E, Fuster-Matanzo A, Lucas JJ, Avila J.
Exp Neurol. 2010 Jun;223(2):322-5. Epub 2009 Sep 24. Review.
Amyloid-beta fibrillogenesis: structural insight and therapeutic intervention.
Dasilva KA, Shaw JE, McLaurin J.
Exp Neurol. 2010 Jun;223(2):311-21. Epub 2009 Sep 8. Review.
Oligomers of beta-amyloid are sequestered into and seed new plaques in the brains of an AD mouse model.
Gaspar RC, Villarreal SA, Bowles N, Hepler RW, Joyce JG, Shughrue PJ.
Exp Neurol. 2010 Jun;223(2):394-400. Epub 2009 Sep 8.
Anti-inflammatory treatment in AD mice protects against neuronal pathology.
Choi JK, Jenkins BG, Carreras I, Kaymakcalan S, Cormier K, Kowall NW, Dedeoglu A.
Exp Neurol. 2010 Jun;223(2):377-84. Epub 2009 Aug 10.
Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs.
Rocher AB, Crimins JL, Amatrudo JM, Kinson MS, Todd-Brown MA, Lewis J, Luebke JI.
Exp Neurol. 2010 Jun;223(2):385-93. Epub 2009 Aug 7.
Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid.
Portelius E, Brinkmalm G, Tran A, Andreasson U, Zetterberg H, Westman-Brinkmalm A, Blennow K, Ohrfelt A.
Exp Neurol. 2010 Jun;223(2):351-8. Epub 2009 Jun 25.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on